V5 Ultimate
Ultimate
PricingResourcesCompany
English (original)العربيةDeutschΕλληνικάEspañolFrançaisItalianoעברית日本語한국어NederlandsPolskiPortuguêsSvenska
Talk to us Log in Start free trial
Food & Beverage
  • Bakery & Confectionery
  • Food Processing
  • Ingredients & Dry Mixes
  • Sausage & Meat Products
  • Produce Packing
  • Pet Food & Pet Supplements
  • Dairy & Chilled Foods
  • Beverages & Liquid Manufacturing
  • Infant Formula
Pharma & Life Sciences
  • Radiopharmaceuticals
  • Pharmaceutical
  • Medical Devices
  • Veterinary Pharmaceuticals
  • Blood & Tissue
  • Diagnostics & IVD Kits
  • Reference Materials & Standards
  • OTC Topical Creams & Gels
Supplements & Personal Care
  • Dietary Supplements
  • Cosmetics & Personal Care
  • Cannabis & Hemp Manufacturing
  • Fragrances & Perfumery
  • Soaps & Personal Hygiene
  • Botanical Extracts & Essential Oils
Chemicals & Materials
  • Plastics & Resins
  • Agricultural Chemicals
  • Specialty & Industrial Chemicals
  • Printing Inks, Pigments & Construction Chemicals
  • Lubricants & Metalworking Fluids
  • Coatings, Adhesives & Sealants
Other Manufacturing
  • Consumer Products
  • Electronics & Electrical Assembly
  • Textiles & Nonwoven
  • Contract Manufacturing & Co-Packing
  • Packaging & Food-Contact Materials
  • Regulated Warehousing & Distribution
Explore all industries
  • Warehouse & TraceabilityReceive, store, pick and trace
  • Production & PlanningPlan jobs and guide production
  • Quality & LaboratoryTest, investigate and review
  • Documents & TrainingControl procedures and qualifications
  • Equipment & PerformanceMaintain assets and measure losses
  • Orders & IntegrationsConnect customers, suppliers and systems
  • Outputs & InsightsReports, KPIs and label design
Why V5? Product & Features
Why V5?Product & Features
  • Warehouse & TraceabilityReceive, store, pick and trace
  • Production & PlanningPlan jobs and guide production
  • Quality & LaboratoryTest, investigate and review
  • Documents & TrainingControl procedures and qualifications
  • Equipment & PerformanceMaintain assets and measure losses
  • Orders & IntegrationsConnect customers, suppliers and systems
  • Outputs & InsightsReports, KPIs and label design
Explore all industries
    • Bakery & Confectionery
    • Food Processing
    • Ingredients & Dry Mixes
    • Sausage & Meat Products
    • Produce Packing
    • Pet Food & Pet Supplements
    • Dairy & Chilled Foods
    • Beverages & Liquid Manufacturing
    • Infant Formula
    • Radiopharmaceuticals
    • Pharmaceutical
    • Medical Devices
    • Veterinary Pharmaceuticals
    • Blood & Tissue
    • Diagnostics & IVD Kits
    • Reference Materials & Standards
    • OTC Topical Creams & Gels
    • Dietary Supplements
    • Cosmetics & Personal Care
    • Cannabis & Hemp Manufacturing
    • Fragrances & Perfumery
    • Soaps & Personal Hygiene
    • Botanical Extracts & Essential Oils
    • Plastics & Resins
    • Agricultural Chemicals
    • Specialty & Industrial Chemicals
    • Printing Inks, Pigments & Construction Chemicals
    • Lubricants & Metalworking Fluids
    • Coatings, Adhesives & Sealants
    • Consumer Products
    • Electronics & Electrical Assembly
    • Textiles & Nonwoven
    • Contract Manufacturing & Co-Packing
    • Packaging & Food-Contact Materials
    • Regulated Warehousing & Distribution
PricingResourcesCompany
Start free trial Log in Talk to us
HomeGlossaryFS
Compliance · The complete guide

FSFunctional Specification

In short

The critical initiation phase of pharmaceutical capital projects that determines technical viability, regulatory risk, and investment logic before design begins.

1,654 words · ~8 min read
Engineer reviewing process diagrams with an industrial plant behind
Engineer reviewing process diagrams with an industrial plant behind
On this page
  1. 01Defining the Feasibility Study (FS)
  2. 02Where the FS Sits in the Project Lifecycle
  3. 03Process Options and Capacity Modeling
  4. 04Site and Utilities Assessment
  5. 05Regulatory and Compliance Constraints
  6. 06Cost Estimates and Project Risk
  7. 07Sign-off and Feeding the URS
  8. 08Common Mistakes in Pharma Feasibility Studies
On this page · 8 sections
  1. 1Defining the Feasibility Study (FS)
  2. 2Where the FS Sits in the Project Lifecycle
  3. 3Process Options and Capacity Modeling
  4. 4Site and Utilities Assessment
  5. 5Regulatory and Compliance Constraints
  6. 6Cost Estimates and Project Risk
  7. 7Sign-off and Feeding the URS
  8. 8Common Mistakes in Pharma Feasibility Studies
AI · Explain it for MY operation

How does FS apply to your shop floor?

Pick your industry and scale — Ask V5 rewrites the definition in your context, gives a worked example, and shows what V5 does on day one.

Your scale

01Defining the Feasibility Study (FS)

In the context of pharmaceutical and biotech capital projects, a Feasibility Study (FS) is the primary investigation conducted at the earliest stage of the project lifecycle. Its objective is to determine if a proposed investment—such as a new manufacturing facility, a line expansion, or a significant process upgrade—is technically achievable, economically viable, and compliant with regulatory expectations 2. It serves as the 'Go/No-Go' gate that prevents organizations from committing millions in capital to projects that lack a clear path to success.

The Abbreviation Collision

In regulated manufacturing, the acronym 'FS' is dual-purpose. While capital project teams use it for the Feasibility Study, validation and IT teams following GAMP 5 use it to mean 'Functional Specification' (the document describing how a system meets its user requirements). In a high-functioning project, the Feasibility Study precedes the Functional Specification by months or years; the FS (Study) defines the broad scope, while the FS (Spec) defines the specific digital or mechanical logic of the resulting system.

A well-executed Feasibility Study does not attempt to solve every engineering detail. Instead, it focuses on identifying 'deal-breakers'—technical constraints, site limitations, or regulatory hurdles that could render the project non-viable. The output is typically a recommendation to the Board or Investment Committee, backed by a range of CAPEX (Capital Expenditure) and OPEX (Operating Expenditure) estimates, a preliminary schedule, and a high-level risk register 3.

V5 Ultimate supports the transition from feasibility to execution by centralizing the regulatory intelligence and capacity assumptions identified in the FS. By capturing the product portfolio and target markets early in the digital record, teams can ensure the subsequent URS and configuration directly address the risks identified during the study phase.

02Where the FS Sits in the Project Lifecycle

The Feasibility Study occupies 'Stage 1' of the pharmaceutical project lifecycle 2. It is distinct from and precedes Conceptual Design, though the two are frequently blurred in smaller projects. Understanding the boundary is essential for effective stage-gate governance.

  • Project Initiation: The 'Idea' phase where business needs are identified.
  • Feasibility Study (FS): 'Is this a good idea?' Focus on viability and broad options.
  • Conceptual Design: 'Identifying the best option.' Translating the idea into layouts and PFDs.
  • Basic Design / FEED: 'How do we build it?' Detailed specifications and long-lead procurement.
  • Detailed Engineering: The final design for construction and installation.

From a regulatory perspective, the FS aligns with the very beginning of 'Stage 1: Process Design' in the FDA's three-stage process validation lifecycle 1. While the FS is a business-driven activity, the technical decisions made here—such as choosing between batch and continuous manufacturing—establish the 'Design Space' that will eventually be qualified. Skipping this stage or rushing through it often leads to 'Scope Creep' in later phases, as fundamental questions about capacity or site suitability remain unanswered while expensive detailed design is underway 4.

03Process Options and Capacity Modeling

The core of any pharmaceutical feasibility study is the translation of a product portfolio into physical requirements. This begins with capacity modeling. The study must determine if the target volumes can be achieved within the proposed shift patterns, equipment sizes, and cycle times 3.

Key considerations in process feasibility include:

  • Technology Selection: Comparing traditional stainless steel vs. single-use technology (SUT), or batch vs. continuous manufacturing (ICH Q13).
  • Throughput Analysis: Modeling batch sizes, turnaround times, and cleaning requirements (CIP/SIP) to ensure the facility doesn't become a bottleneck.
  • Material Compatibility: Assessing the handling requirements for highly potent APIs (HPAPI), flammable solvents, or light-sensitive compounds.
  • Future-Proofing: Determining the level of 'spare capacity' or modularity needed to accommodate future products not yet in the pipeline.

Mistakes in capacity modeling during the FS are among the most expensive to fix. If the batch size is sized incorrectly for the utility loads (e.g., purified water demand during peak cleaning cycles), the facility may never reach its rated nameplate capacity without significant rework of the underlying infrastructure.

04Site and Utilities Assessment

A feasibility study must evaluate the 'Host' for the new process. This could be a 'Greenfield' site (raw land), a 'Brownfield' site (existing industrial site), or an 'Interior Fit-out' (within an existing shell). Each carries vastly different risk profiles regarding utilities and infrastructure 5.

The FS examines the 'Black Utilities' (standard industrial utilities like electricity, natural gas, and city water) and their capacity to support the 'Clean Utilities' (Purified Water, WFI, Clean Steam, Process Gases). Specifically, the study looks for:

  • Power Reliability: Does the local grid support the uptime required for sensitive biologics, or is a dedicated substation and backup generation required?
  • Water Quality and Quantity: Can the local municipal supply meet the raw water demand for WFI generation, especially during peak demand periods?
  • Environmental Impact: Wastewater treatment capacity and emissions permits required for the specific process chemistry.
  • Structural Suitability: For interior fit-outs, can the existing slab support the weight of heavy equipment like bioreactors, tablet presses, or lyophilizers?

05Regulatory and Compliance Constraints

In the life sciences, feasibility is as much about 'Permittability' as it is about engineering. The FS must identify the regulatory pathway for the product in its target markets (FDA, EMA, NMPA, etc.) 3. This includes determining the required Cleanroom Grades (ISO/EU) and the containment strategies necessary to prevent cross-contamination.

A critical output of the FS is the 'Regulatory Roadmap,' which outlines:

  • Zoning Requirements: High-level segregation strategy for allergens, penicillins, or live viruses.
  • Glove/Barrier Strategy: Preliminary decision on whether to use isolators, RABS (Restricted Access Barrier Systems), or traditional cleanrooms.
  • Qualification Strategy: How the project will align with Annex 15 and the company's Validation Master Plan (VMP).
  • Audit Trail Requirements: Identifying which processes will require 21 CFR Part 11 compliant digital records.
The Compliance Trap

Many feasibility studies fail because they assume 'standard GMP' is sufficient. However, if a product is intended for the EU market, the facility must comply with specific Annex 1 requirements for sterile manufacturing, which may dictate airlocks and personnel flows that are not required by other jurisdictions. Identifying these gaps in the FS prevents massive redesign costs during DQ (Design Qualification).

06Cost Estimates and Project Risk

The financial deliverable of a Feasibility Study is typically a 'Class 4' or 'Class 5' estimate (per AACE International standards), which usually carries an accuracy range of +50% / -30% 4. The goal is not precision, but a 'Budget Envelope' that allows for an investment decision.

Parallel to the cost estimate is the Project Risk Register. Unlike the Quality Risk Management (QRM) activities that happen during design, the FS risk register focuses on macro-risks:

  • Supply Chain Risk: Long-lead times for critical equipment (e.g., custom bioreactors or high-speed fillers).
  • Geopolitical Risk: Regulatory changes or trade barriers in target markets.
  • Technical Risk: Novel process technology that has not been proven at scale.
  • Resource Risk: Availability of skilled labor for construction and eventual operation in the selected geography.

07Sign-off and Feeding the URS

A Feasibility Study is typically signed off by a cross-functional group of senior stakeholders, including Finance, Operations, Engineering, and Quality Assurance 2. This sign-off represents the 'Authorization to Spend' on the next phase: Conceptual Design and the development of the User Requirements Specification (URS).

The FS directly feeds the URS by establishing the 'Business Requirements' that the URS will formalize. For example, if the FS determines that a 24/7 continuous process is necessary for viability, the URS must then specify the automated diversion valves and PAT (Process Analytical Technology) requirements to support that state of control. Without a solid FS, the URS often lacks the context needed to make informed technical trade-offs.

V5 Ultimate facilitates this handover by allowing teams to anchor their initial feasibility assumptions—such as target batch sizes and critical process steps—directly into the platform's configuration roadmap. As the project moves into the URS and DQ phases, the 'why' behind the design remains visible to the entire team, preventing the loss of institutional knowledge that often occurs when projects change hands between planning and execution.

08Common Mistakes in Pharma Feasibility Studies

Even experienced teams fall into predictable traps during the feasibility phase. The most common including:

  1. Optimistic Capacity Modeling: Assuming 100% equipment availability and ignoring the time required for cleaning validation and line clearance between batches.
  2. Ignoring 'Hidden' Infrastructure: Budgeting for the process equipment but underestimating the cost of the HVAC, mezzanine structures, and effluent treatment required to support it.
  3. Late QA Involvement: Waiting until Conceptual Design to bring in Quality Assurance, only to find that the proposed layout violates basic segregation principles.
  4. Underestimating Regulatory Timelines: Factoring in the construction schedule but ignoring the 'Regulatory Clock'—the time required for agency inspections and license approvals before commercial manufacturing can begin.

Frequently asked questions

Q.What is the difference between a Feasibility Study and Conceptual Design?+

The Feasibility Study (FS) focuses on 'If'—if the project makes sense commercially, technically, and regulatory. Conceptual Design focuses on 'How'—developing the specific layouts, process flow diagrams, and zoning strategies for the selected option. FS identifies options; Conceptual Design develops the chosen one.

Q.Who is responsible for the Feasibility Study?+

It is usually led by a Project Manager or a Business Development lead, with heavy input from Process Engineering and Finance. Quality Assurance (QA) must review the study to ensure the proposed regulatory roadmap is sound, but they do not typically 'own' the document.

Q.Does a Feasibility Study need to be validated?+

No. The FS is a business and engineering planning document. However, it is a critical input for Design Qualification (DQ). The data used in the FS (such as clinical trial success rates or market forecasts) is not 'GMP data,' but the technical conclusions (such as required batch sizes) become the basis for GxP requirements in the URS.

Q.How accurate should the cost estimate be in an FS?+

Typically, a Feasibility Study aims for a +50% / -30% accuracy (AACE Class 4/5). The goal is to provide enough confidence for an 'Initial Investment Decision' or to fund the Conceptual Design phase, where a more accurate Class 3 estimate will be developed.

Primary sources

  • ISPE Good Practice Guide: Project Management for the Pharmaceutical Industry
  • FDA Guidance for Industry: Process Validation: General Principles and Practices
  • ISPE Baseline Guide Vol 5: Commissioning & Qualification
  • Pharmaceutical Project Management Checklist (Sample)

Further reading

  • User Requirements Specification (URS)
    The next step after feasibility: defining the specific needs the system must meet.
  • Design Qualification (DQ)
    The formal proof that the proposed design satisfies the URS and FS requirements.
  • EU GMP Annex 15
    The regulatory framework for qualification and validation that governs the project lifecycle.
  • Process Validation Lifecycle
    Understanding how Stage 1 (Design) begins with the feasibility decisions.
  • GAMP 5
    The framework for validated IT systems, where 'FS' often refers to a Functional Specification.
Software that covers FS
V5 Ultimate Quality Control Software
In-process checks, sampling plans, spec limits, SPC trending, CoA generation and hold/release — enforced at the kiosk while the…
V5 Ultimate for CSV / CSA
Requirements traceability, test evidence, change impact and periodic review in one place. Your QA approves the validation; IQ/OQ…
V5 Ultimate (Validation Management)
V5 Ultimate helps life-science sites manage Computer System Validation (CSV) and Computer Software Assurance (CSA) work: linked…

Explore this topic

FS sits inside 2 overlapping topic clusters in our glossary. Every neighbour is one click away.

Part 11 & Data Integrity
24 related entries

Electronic records, signatures, audit trail and ALCOA+ data-integrity principles.

21 CFR Part 11EU Annex 11E-SignatureTwo-Person e-SignatureAudit TrailALCOA+Data IntegrityCSVCSAGAMP 5IQ / OQ / PQURSDSDQPPQVMPAnnex 15Traceability MatrixSSO / SAMLRBACSOC 2HIPAAChange ControlDocument control
Validation & Qualification
16 related entries

URS-through-PQ lifecycle, GAMP 5 categorisation and CSA's modern alternative.

URSDSDQIQ / OQ / PQPPQCPVVMPAnnex 15Traceability MatrixGAMP 5CSVCSAICH Q9ICH Q2Design VerificationChange Control
Talk to us about FS

Want to see how FS could fit into your own records and workflows? Explore the related V5 pages or talk to our team about what applies to your operation.

Start free
Back to glossary
Inside V5
  • → Score your compliance gap — then download the validation pack.
Regulatory anchors
  • GAMP 5
Related terms
  • → URS
  • → DS
  • → GAMP 5
  • → IQ / OQ / PQ
  • → Traceability Matrix
  • → 21 CFR Part 11
  • → EU Annex 11
  • → E-Signature
  • → Two-Person e-Signature
  • → Audit Trail
  • → ALCOA+
  • → Data Integrity
  • → CSV
  • → CSA
  • → DQ
  • → PPQ
  • → VMP
  • → Annex 15
  • → SSO / SAML

Next Step

Try V5 with your own records, or ask a question first. Ask V5 opens with an editable question; nothing is sent until you choose to.

Start your free trial Browse All Features

Showing the site for the United States. Local spelling, dates and prices are applied automatically; change the language at the top of the page.

V5 Ultimate
Ultimate

Warehouse, quality and manufacturing software for regulated operations.

ProductIndustriesPricingResourcesSecurity & TrustCompanyLegal Centre

© S.G. Systems, LLC